|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,456.00 JPY | -1.96% |
|
-1.33% | -2.42% |
| 05-15 | ALCONIX Corporation Reports Earnings Results for the Full Year Ended March 31, 2026 | CI |
| 05-15 | Alconix Corporation Provides Dividend Guidance for the Year Ending March 31, 2027 | CI |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.25 | 2.85 | 1.82 | 2.28 | 2.91 | |||||
Return on Total Capital | 6.22 | 4.13 | 2.66 | 3.52 | 4.61 | |||||
Return On Equity % | 15.08 | 9.2 | 2.55 | 7.13 | 7.55 | |||||
Return on Common Equity | 15.06 | 9.19 | 2.49 | 7.09 | 7.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 16.49 | 14.06 | 13.11 | 13.21 | 13.94 | |||||
SG&A Margin | 8.52 | 9.32 | 10 | 9.7 | 9.46 | |||||
EBITDA Margin % | 9.7 | 7.43 | 5.86 | 5.96 | 6.61 | |||||
EBITA Margin % | 7.46 | 5.2 | 3.32 | 3.68 | 4.6 | |||||
EBIT Margin % | 7.05 | 4.71 | 3.12 | 3.51 | 4.43 | |||||
Income From Continuing Operations Margin % | 4.86 | 3.11 | 0.94 | 2.47 | 2.58 | |||||
Net Income Margin % | 4.8 | 3.08 | 0.91 | 2.44 | 2.55 | |||||
Net Avail. For Common Margin % | 4.8 | 3.08 | 0.91 | 2.44 | 2.55 | |||||
Normalized Net Income Margin | 4.35 | 2.84 | 1.92 | 2.35 | 2.64 | |||||
Levered Free Cash Flow Margin | -6.79 | -3.52 | 7.78 | -0.66 | -2.08 | |||||
Unlevered Free Cash Flow Margin | -6.58 | -3.22 | 8.17 | -0.36 | -1.78 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.96 | 0.97 | 0.93 | 1.04 | 1.05 | |||||
Fixed Assets Turnover | 6.52 | 6.25 | 5.49 | 5.7 | 5.72 | |||||
Receivables Turnover (Average Receivables) | 2.9 | 2.96 | 2.97 | 3.32 | 3.38 | |||||
Inventory Turnover (Average Inventory) | 3.73 | 3.29 | 3.08 | 3.23 | 3.06 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.43 | 1.44 | 1.48 | 1.4 | 1.35 | |||||
Quick Ratio | 0.9 | 0.88 | 0.87 | 0.79 | 0.74 | |||||
Operating Cash Flow to Current Liabilities | -0.04 | 0 | 0.17 | 0.07 | 0.02 | |||||
Days Sales Outstanding (Average Receivables) | 125.98 | 123.27 | 123.29 | 109.83 | 108 | |||||
Days Outstanding Inventory (Average Inventory) | 97.78 | 110.82 | 118.75 | 112.84 | 119.17 | |||||
Average Days Payable Outstanding | 96.02 | 96.78 | 103.29 | 100.48 | 103.73 | |||||
Cash Conversion Cycle (Average Days) | 127.74 | 137.31 | 138.76 | 122.18 | 123.43 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 107.79 | 113.92 | 83.19 | 76.43 | 75.4 | |||||
Total Debt / Total Capital | 51.87 | 53.25 | 45.41 | 43.32 | 42.99 | |||||
LT Debt/Equity | 32.88 | 33.16 | 27.62 | 21.55 | 16.85 | |||||
Long-Term Debt / Total Capital | 15.82 | 15.5 | 15.08 | 12.21 | 9.61 | |||||
Total Liabilities / Total Assets | 67.51 | 67.14 | 63.72 | 64.24 | 64.06 | |||||
EBIT / Interest Expense | 21.24 | 9.99 | 4.97 | 7.11 | 9.3 | |||||
EBITDA / Interest Expense | 29.2 | 15.77 | 9.33 | 12.06 | 13.85 | |||||
(EBITDA - Capex) / Interest Expense | 21.23 | 10.17 | 6.39 | 5.34 | 5.79 | |||||
Total Debt / EBITDA | 4.08 | 5.42 | 5.38 | 4.58 | 4.15 | |||||
Net Debt / EBITDA | 2.32 | 3.38 | 3.29 | 2.98 | 2.67 | |||||
Total Debt / (EBITDA - Capex) | 5.61 | 8.41 | 7.85 | 10.35 | 9.94 | |||||
Net Debt / (EBITDA - Capex) | 3.19 | 5.25 | 4.8 | 6.74 | 6.39 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -27.3 | 14.11 | -1.92 | 12.64 | 11.53 | |||||
Gross Profit, 1 Yr. Growth % | 38.74 | -2.68 | -8.59 | 13.52 | 17.7 | |||||
EBITDA, 1 Yr. Growth % | 58.91 | -12.6 | -22.6 | 14.45 | 23.74 | |||||
EBITA, 1 Yr. Growth % | 86.46 | -20.52 | -37.41 | 25.06 | 39.41 | |||||
EBIT, 1 Yr. Growth % | 96 | -23.84 | -34.91 | 26.65 | 40.81 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 162.17 | -27.08 | -70.21 | 195.33 | 16.42 | |||||
Net Income, 1 Yr. Growth % | 162.48 | -26.89 | -70.88 | 200.69 | 16.5 | |||||
Normalized Net Income, 1 Yr. Growth % | 93.36 | -25.5 | -33.76 | 38.37 | 25.01 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 148.75 | -35.44 | -70.91 | 200.32 | 17.01 | |||||
Accounts Receivable, 1 Yr. Growth % | 19.67 | 4.94 | -8.96 | 11.13 | 8.36 | |||||
Inventory, 1 Yr. Growth % | 66.22 | 13.14 | -0.36 | 14.78 | 18.55 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.7 | 27.66 | -0.8 | 17.76 | 5.42 | |||||
Total Assets, 1 Yr. Growth % | 19.28 | 8.76 | -4.69 | 7.51 | 13.12 | |||||
Tangible Book Value, 1 Yr. Growth % | 40.31 | 12.66 | 6.62 | 6.46 | 14.84 | |||||
Common Equity, 1 Yr. Growth % | 32.71 | 9.94 | 5.16 | 6.01 | 13.71 | |||||
Cash From Operations, 1 Yr. Growth % | -181.23 | -106.79 | 6.63K | -53.97 | -65.39 | |||||
Capital Expenditures, 1 Yr. Growth % | 45.8 | 13.76 | -31.46 | 102.85 | 29.27 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -2.23K | -40.89 | -316.84 | -109.63 | 248.52 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.4K | -44.13 | -348.58 | -104.91 | 457.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 23.81 | 3.85 | 1.85 | 34.55 | 17.57 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -17.97 | -8.92 | 5.79 | 5.1 | 12.08 | |||||
Gross Profit, 2 Yr. CAGR % | 17.63 | 16.2 | -5.68 | 1.87 | 15.59 | |||||
EBITDA, 2 Yr. CAGR % | 30.86 | 17.85 | -17.75 | -5.88 | 19 | |||||
EBITA, 2 Yr. CAGR % | 41.77 | 21.73 | -29.47 | -11.52 | 32.04 | |||||
EBIT, 2 Yr. CAGR % | 45.91 | 22.18 | -29.59 | -9.2 | 33.54 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 45.45 | 38.26 | -53.39 | -6.2 | 85.42 | |||||
Net Income, 2 Yr. CAGR % | 44.07 | 38.52 | -53.86 | -6.43 | 87.17 | |||||
Normalized Net Income, 2 Yr. CAGR % | 43.74 | 20.02 | -29.75 | -4.27 | 31.52 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 40.45 | 26.72 | -56.67 | -6.54 | 87.46 | |||||
Accounts Receivable, 2 Yr. CAGR % | 16.18 | 12.07 | -2.25 | 0.59 | 9.73 | |||||
Inventory, 2 Yr. CAGR % | 29.34 | 37.14 | 6.17 | 6.94 | 16.65 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 9.49 | 18.34 | 12.53 | 8.08 | 11.42 | |||||
Total Assets, 2 Yr. CAGR % | 14.55 | 13.9 | 1.81 | 1.23 | 10.28 | |||||
Tangible Book Value, 2 Yr. CAGR % | 24.2 | 25.73 | 9.6 | 6.54 | 10.57 | |||||
Common Equity, 2 Yr. CAGR % | 18.47 | 20.79 | 7.52 | 5.58 | 9.79 | |||||
Cash From Operations, 2 Yr. CAGR % | -39.49 | -76.52 | 113.79 | 456.66 | -60.09 | |||||
Capital Expenditures, 2 Yr. CAGR % | 14.92 | 28.79 | -11.7 | 17.91 | 61.93 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.55 | 255.19 | 13.21 | -54.31 | -42.07 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 17.03 | 169.38 | 17.85 | -65.06 | -47.69 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.27 | 13.39 | 2.84 | 17.06 | 25.77 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -15.33 | -8.43 | -6.65 | 8.02 | 7.2 | |||||
Gross Profit, 3 Yr. CAGR % | 10.29 | 10.43 | 7.26 | 0.33 | 6.89 | |||||
EBITDA, 3 Yr. CAGR % | 17.56 | 14.39 | 2.44 | -8.18 | 3.11 | |||||
EBITA, 3 Yr. CAGR % | 19.55 | 16.9 | -2.48 | -14.63 | 2.95 | |||||
EBIT, 3 Yr. CAGR % | 20.76 | 17.48 | -0.95 | -14.37 | 5.1 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 22.83 | 15.55 | -17.11 | -13.75 | 0.81 | |||||
Net Income, 3 Yr. CAGR % | 23.26 | 14.91 | -17.64 | -13.82 | 0.66 | |||||
Normalized Net Income, 3 Yr. CAGR % | 22.86 | 15.46 | -1.55 | -11.94 | 4.64 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 22.11 | 8.39 | -22.41 | -17.38 | 0.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | 8.23 | 12.31 | 4.57 | 2.02 | 3.11 | |||||
Inventory, 3 Yr. CAGR % | 13.74 | 23.7 | 23.29 | 8.97 | 10.68 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 10.05 | 15.24 | 11.58 | 14.25 | 7.19 | |||||
Total Assets, 3 Yr. CAGR % | 7.04 | 12.59 | 7.33 | 3.68 | 5.05 | |||||
Tangible Book Value, 3 Yr. CAGR % | 20.04 | 20.23 | 19 | 8.54 | 9.24 | |||||
Common Equity, 3 Yr. CAGR % | 14.47 | 15.56 | 15.34 | 7.02 | 8.23 | |||||
Cash From Operations, 3 Yr. CAGR % | -14.25 | -70.81 | 54.85 | 28.13 | 120.53 | |||||
Capital Expenditures, 3 Yr. CAGR % | 18.85 | 14.53 | 4.37 | 16.51 | 21.58 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 454.54 | -3.89 | 201.31 | -50.21 | -10.05 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 205.69 | -8.53 | 162.26 | -59.14 | -12.05 | |||||
Dividend Per Share, 3 Yr. CAGR % | 10.06 | 8.74 | 9.41 | 12.48 | 17.23 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -5 | -6.38 | -7.44 | -3.24 | 0.44 | |||||
Gross Profit, 5 Yr. CAGR % | 12.22 | 5.66 | 3.6 | 6.92 | 10.52 | |||||
EBITDA, 5 Yr. CAGR % | 19.22 | 5.7 | 1.91 | 5.8 | 8.77 | |||||
EBITA, 5 Yr. CAGR % | 20.11 | 3.32 | -3.2 | 4.57 | 10.09 | |||||
EBIT, 5 Yr. CAGR % | 21.46 | 2.76 | -2.68 | 5.98 | 11.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 18.88 | 0.2 | -16.64 | 6.3 | 14.39 | |||||
Net Income, 5 Yr. CAGR % | 19.48 | 0.56 | -16.8 | 5.84 | 14.38 | |||||
Normalized Net Income, 5 Yr. CAGR % | 21.14 | 1.47 | -1.76 | 7.12 | 10.54 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 18.76 | -2.42 | -19.32 | 2.15 | 10.42 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.62 | 5.44 | 3.91 | 7.46 | 6.6 | |||||
Inventory, 5 Yr. CAGR % | 17.56 | 15.47 | 10.65 | 16.7 | 20.59 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 18.78 | 16.65 | 11.04 | 12.32 | 11.52 | |||||
Total Assets, 5 Yr. CAGR % | 9.2 | 8 | 4.92 | 7.9 | 8.5 | |||||
Tangible Book Value, 5 Yr. CAGR % | 16.79 | 15.08 | 15.75 | 14.55 | 15.56 | |||||
Common Equity, 5 Yr. CAGR % | 11.91 | 11.17 | 11.64 | 11.46 | 13.09 | |||||
Cash From Operations, 5 Yr. CAGR % | 88.47 | -39.76 | 23.58 | -5.09 | -9.97 | |||||
Capital Expenditures, 5 Yr. CAGR % | 18.91 | 19.09 | 5.53 | 15.87 | 24.41 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 32.83 | 22.06 | 193.71 | -28.62 | 55.8 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 34.34 | 23.56 | 108.79 | -37.76 | 37.62 | |||||
Dividend Per Share, 5 Yr. CAGR % | 18.77 | 11.03 | 7.12 | 11.99 | 15.68 |
- Stock Market
- Stocks
- 3036 Stock
- Financials ALCONIX Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















